Alkermes | Investor Conference Presentation Deck | 36 slides

Alkermes · 2022-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

36
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
summarize
04
summarize
05
summarize
06
transition
Open slide detailBeat · Problem
07
The slide serves as a portfolio overview of the company's key commercial assets.other
Open slide detailBeat · Problem
08
front_matter
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
09
Includes boxed warning and clinical trial citations.summarize
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
10
The diagram shows a central hub of commercial capabilities being applied to two products (ARISTADA and LYBALVI).present_solution
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
11
The slide uses a 3-circle Venn diagram to define the target audience segment.prioritize
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
12
The chart shows a dual-axis line graph tracking weekly TRx and cumulative prescribers over 10 weeks.analyze_data
Open slide detailBeat · SolutionLoop · Quick Win Big Bet
13
establish_context
Open slide detailBeat · Market Size
14
Includes product branding, imagery of patients, and a footnote detailing the ARISTADA INITIO regimen.establish_context
Open slide detailBeat · Market Size
15
The slide uses a bar chart for historical sales and a grouped bar chart for market comparison.analyze_data
Open slide detailBeat · Market Size
16
establish_context
Open slide detailBeat · Market Size
17
Includes product imagery and prescribing information link.establish_context
Open slide detailBeat · Product
18
The slide highlights the correlation between overall net sales and the specific growth in alcohol dependence utilization, noting a COVID-19 impact in 2020.analyze_data
Open slide detailBeat · Product
19
The slide acts as a portfolio overview of the company's primary commercial assets.establish_context
Open slide detailBeat · Product
20
establish_context
Open slide detailBeat · Product
21
analyze_data
22
The chart illustrates revenue diversification over time with the addition of VUMERITY.analyze_data
23
front_matter
Open slide detailLoop · Cost Of Inaction
24
present_framework
Open slide detailLoop · Cost Of Inaction
25
The slide uses a horizontal bar chart format to represent the progress of various drug candidates.present_solution
Open slide detailLoop · Cost Of Inaction
26
summarize
Open slide detailLoop · Cost Of Inaction
27
The slide uses a human body diagram to map tumor types treated with monotherapy vs. combination therapy.summarize
Open slide detailLoop · Cost Of Inaction
28
present_solution
Open slide detailLoop · Cost Of Inaction
29
The slide uses a matrix-like layout to organize clinical trials (ARTISTRY series) by their strategic purpose (Registration, Dose, Collaboration).present_framework
Open slide detailLoop · Cost Of Inaction
30
The slide includes a molecular visualization of the HDAC1/2-CoREST complex.present_solution
Open slide detailLoop · Cost Of Inaction
31
present_solution
Open slide detailLoop · Cost Of Inaction
32
Includes a medical diagram of the brain showing orexin pathways.frame_problem
Open slide detailLoop · Cost Of Inaction
33
Includes a molecular structure visualization of OX2R in complex with Orexin-B.present_solution
Open slide detailLoop · Cost Of Inaction
34
plan_implementation
Open slide detailLoop · Cost Of Inaction
36
state_next_steps